Clinical Trial Update: Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Combivent Aerosol and Spacer for adults with moderate to severe asthma crisis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Combivent Aerosol (ipratropium bromide and albuterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: TERMINATED